Download Files:
Products Details
Product Description
– XJ02862-S2 shows potent FXR agonistic activity. XJ02862-S2 is a promising lead compound for the research of NAFLD[1].
Web ID
– HY-149971
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C27H31N3O3
References
– [1]Tong Qin, et al. Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease. Eur J Med Chem. 2023 Apr 5;252:115307.
Molecular Weight
– 445.55
SMILES
– C[C@H]1C[C@H](C2=CC=CC=C2N1C([C@@H](N3C(C4CCCCC4C3=O)=O)C)=O)NC5=CC=CC=C5
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– FXR
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
